Abstract
As a major expense driver to cardiovascular programs, supply costs related to electrophysiology and cardiac catheterization procedures directly link to the overall financial health of organizations associated with those programs. Because of this, it is important that institutions establish a logical and resolute approach to obtaining supply pricing that maximizes cost-saving opportunities, buffers their organizations from escalating costs related to the advances in available technologies, defines supply chain expectations while preserving clinicians' access to high-quality cardiovascular supplies, and maintains the availability of the full spectrum of products to our physicians, referring physicians, and patients. In a joint effort with physicians, administration, and suppliers, and in the spirit of partnership, the University of Michigan Health System has developed and implemented such a model that illustrates the opportunities to be gained.